BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Via Surgical Appoints Stephen Blumenreich as the Board of Directors Observer


5/29/2012 12:03:51 PM

AMIRIM, Israel, May 29, 2012 /PRNewswire/ --

Mr. Blumenreich, an investment banker at Raymond James, brings nearly 20 years of experience advising growth-oriented medical device companies and has completed numerous capital raising and M&A transactions in the aesthetics, cardiovascular, diabetes, diagnostics, general surgery, orthopedics, and spine subsectors. He joined Raymond James in 2012 when the firm acquired Morgan Keegan & Co., where Blumenreich worked since 2009 as a managing director. Prior to that, he was co-head of the Medical Device Group at Thomas Weisel Partners where he helped build one of the leading medical device underwriters on Wall Street. He began his career in the M&A Group at Salomon Brothers before joining Alex. Brown & Sons in the Health Care Group. Blumenreich received an MBA from the Wharton School of the University of Pennsylvania and an AB from Dartmouth College.

"Stephen's deep experience in the medical device industry and his outstanding track record of fundraising, and M&A transactions will be of great value in forming corporate strategy. I am delighted to have Stephen on our team," remarked Ofek Levin, Founder and CEO of Via Surgical.

Mr. Blumenreich commented, "I am looking forward to joining Via Surgical. I worked with Ofek and his team at PolyTouch Medical and was very impressed with how successfully they built the PolyTouch business. Via Surgical's technology is targeting an area that looks even more exciting to me."

As previously reported, PolyTouch announced on May 09 that it has appointed Karl A. LeBlanc, MD, MBA, FACS, and David B. Earle MD, FACS as Medical Advisors.

About Via Surgical Ltd.

Via Surgical was founded by Lena Levin, Arik Levy and Ofek Levin the winners of BIZTEC07, Israel national entrepreneurship competition and the founders of PolyTouch Medical - recently acquired by Covidien. Realizing the need for an improved hernia mesh fixation solution, Via Surgical has developed SutureLAP[TM], a novel hernia mesh fixation device with the potential to significantly improve clinical outcomes.

Please visit http://www.viasurgical.com to learn more about Via Surgical Ltd.

Contact:
Ofek Levin
Founder & CEO
Via Surgical Ltd.
ofek@viasurgical.com
Phone: +972-52-639-5765


SOURCE Via Surgical Ltd.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES